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Background and Objective 
Large randomised clinical trials comparing long term survival in patients undergoing 
laparoscopic and open colectomy show equivalence, however meaningful analysis of data by 
stage has not been possible due to small numbers within individual trials. The aim of this 
meta-analysis is to improve the power by combining data to enable assessment of survival for 
individual stages. 
Methods 
A formal systematic review and meta-analysis was conducted. A computerised search of all 
Randomised Controlled Trials (RCTs) was performed. Overall survival data was analysed 
and subgroup analysis performed for cancer stages I-III. 
Results    
Five trials (n = 3152 patients) were included. Overall survival was equivalent (HR: 0.93, 95 
CI: 0.80-1.07). With each of the cancer stages I-III there was no difference in outcomes for 5 
year survival. There was however a non-significant trend in favour of open surgery in the 
sub-group analysis of Stage II patients. 
Conclusions   
Laparoscopic assisted surgery for colon cancer is equivalent to open surgery with respect to 
long term survival.  
 
WHAT DOES THIS PAPER ADDS TO THE LITERATURE? 
This paper includes long term data from all large RCTs on long term survival following 
laparoscopic and open colon cancer surgery. It is the only such meta-analysis to exclude all 
rectal cancers from the analysis to ensure accuracy. The increased numbers enabled sub-




Surgery is the mainstay for cure for colorectal cancer and until the introduction of 
laparoscopic colectomy in 1991
6, 9
, laparotomy was the main surgical approach utilised. Short 
term benefits of laparoscopic colectomy over open colon resection such as decreased length 
of stay, shorter return to function and better cosmesis have now been proven
22
. Subsequently, 
the debate has moved to the possibility of differences in oncological outcomes between the 
two techniques. 
 
Evidence to date regarding long-term survival comparing laparoscopic versus open resection 
for colon cancer has been mainly from the results of large scale Randomised Controlled 
Clinical Trials (RCTs) and some case series. Although there have been meta-analyses looking 
at some of these trials, showing equivalence, these did not include the long term data from all 
of them and did not exclude the rectal cancers in the UK MRC CLASICC trial
4
.  More 
recently, the Australasian Laparoscopic Colon Cancer Study (ALCCaS)
1
 have released their 5 
year survival outcomes that can now be included. In addition, there has been no subgroup 
analysis by cancer stage within the published meta-analyses. 
 
The aim of this study was to undertake a meta-analysis of the overall survival results for 
clinical trials comparing laparoscopic versus open surgery in only patients with colon cancer.  







In compliance with Quality of Reporting of Meta-analyses (QUORUM) guidelines
16
, an 
initial systematic literature review was undertaken.  
 
Search strategy 
A computerised search was undertaken using the MOOSE (Meta-analysis of Observational 
Studies in Epidemiology) guidelines
23
. The Cochrane developed Highly Sensitive Search 
Strategy (HSSS) was employed when searching Medline (Ovid and Pubmed) (figure 1). The 
Cochrane Library and Embase were also searched for studies that met the inclusion criteria 
within the years 1990-2010.  MeSh terms included ‘laparoscopic’, ‘surgery’, ‘colon’ and 
‘cancer’. Reference lists of suitable retrieved articles and of prior meta-analyses were also 
searched. There were no language restrictions.  Most recent data from established trials were 
sought from the trial investigators and statisticians. 
 
Study Selection 
Published Randomised Controlled Trials (RCTs) comparing laparoscopic with open 
colectomy for colon cancer from 1990-2010 were selected. Updated, unpublished data 
received directly from the statisticians for these trials was also included.  In order to be 
included, studies had to have at-least 3 year survival data and have outcome measures that 
primarily included overall survival.  
 
Rectal cancers were excluded. Studies that included benign pathology in analyses were 
excluded in addition to those that did not meet the inclusion criteria above.  A flow diagram 





Log hazard ratios and their variance were used as the summary outcome measure from all 
trials in the meta-analysis. Published hazard ratios were used then available, or estimated 
from log rank p-values or from a combination of number of deaths, numbers at risk and 
Kaplan-Meier survival curves. Formulae from Parmar et al
19
 were utilised to enable 
extraction and estimation of the log hazard ratios. Analysis of aggregated data was performed 
using metan in STATA 12.0. The log hazard ratios were graphed on Forest plots using 
Inverse-Variance weighted fixed effect methods (I-V pooled) and DerSimonian and Laird 
random effects methods (D+L pooled).  Heterogenity was assessed using the I2 statistic, 
which is the percentage of between-study heterogeneity that is attributable to variability in 
the true treatment effect rather than sampling variation.  Only fixed effects estimates are 
reported in the absence of evidence of heterogeneity.  The presence of bias was assessed 
















Five Trials were identified and included in this meta-analysis: Barcelona Trial
12
 , Clinical 
Outcomes of Surgical Therapy (COST)
7
, Colon Cancer Laparoscopic or Open Resection 
(COLOR)
3
, Conventional vs. Laparoscopic-Assisted Surgery in Patients with Colorectal 
Cancer (CLASICC)
10




Of these, four were multicentre and one
12
 was from a single institution; overall, procedures 
were carried out in 136 centres. Only the CLASICC study included rectal cancers, but these 
were excluded from analysis. All studies excluded transverse colon cancers and emergency 
presentations with bowel obstruction.  Basic study characteristics are summarised in Table 1. 
All of the trials had ethics approval. Surgeons in the COST, CLASICC and COLOR trials 
required credentialing with at least 20 laparoscopic colectomies to be eligible. Within the 
Barcelona and ALCCAS trials, surgeons were noted to be experienced, with the former 
having one surgical team performing all procedures. Randomisation was 1:1 in all except the 
CLASICC trial which undertook a 2:1 randomisation in favour of laparoscopic procedures. 




Final analysis was carried out on information from the five studies previously described. 
With the CLASICC trial, which included surgery on rectal cancers, colon-only data was 
obtained directly from the study statistician to enable inclusion.  All studies had 5 year 
survival data available for extraction from either published figures or from correspondence 
with the authors and respective statisticians.  For those studies reporting conversions from the 
6 
 
laparoscopic to the open approach, the intention to treat figures were used. Overall survival 
figures for all trial patients include those with Stage IV disease. Although most studies 
excluded these patients, some were diagnosed at operation and included in the final analysis 
as part of the intention to treat analysis.  
 
Overall survival (all-cause mortality) as estimated from the total number of deaths that 
occurred in the follow up period, was used as the primary outcome measure for analysis. 
Only overall survival figures were used from the studies. Most studies did not define overall 
survival but reported total patients in each study arm and total number of deaths in each arm. 
Start time was either from the date of randomisation (COST, CLASICC) or from date of 
surgery (Barcelona), but not mentioned in two trials (ALCCaS, COLOR).  
 
Information for sub-group analysis by Stage for overall survival, was available for the 
COLOR, COST and Barcelona trials by extraction of estimated log hazard ratios from  
Kaplan-Meier survival curves in the published material. Similar information for the 
CLASICC and ALCCaS trials were obtained via correspondence with the statisticians of the 
respective studies. The CLASICC trial reported Duke staging. For the purposes of inclusion 
in the final analysis by stage Dukes A, B and combined C1 and C2 were treated as Stages I, II 
and III respectively. Allowance was made for the 2:1 randomisation of laparoscopic to open 





This meta-analysis included five trials with information on long-term survival, with a total of 
3152 patients (n=1510 open, n= 1642 laparoscopic). The vast majority of patients were in the 
Stage II group (1318 patients, 42%), with the least number of patients in Stage I (n=714, 
7 
 
23%). There were a small number of patients (n=155) who were discovered to have more 
advanced disease at the time of operation and were included in the final results of all stages 
as part of the intention to treat analysis in all studies. 
 
Overall there was some evidence of  heterogeneity between the studies (I2 = 32%) but this 
did not reach significance (p=0.206) on the combined data.  With respect to subgroup 
analysis, there was no significant heterogeneity in Stage I (p =0.853) and Stage II (p=0.872) 
studies. With Stage III there was evidence of heterogeneity amongst the studies with an I
2
 of 
60% (p=0.039). The presence of between-study heterogeneity means that the fixed-effect 
assumption (that the true treatment effect is the same in each study) may be incorrect.  
Therefore, random-effects models were also generated for Stage III studies and the overall 
data and are shown on the Forest plot (Figure 3).  There were no obvious asymmetries 
observed when bias was assessed using Funnel plots with little evidence of small study 
effects and publication bias (data not shown). A summary of the potential risks of study 
biases are also included in Table 1. 
 
In the combined results, there was no statistical difference in long term overall survival 
between the laparoscopic and open surgery groups (HR: 0.93, 95 CI: 0.80-1.07). The sub-
group analysis showed no significant difference in overall survival at 5 years between 
laparoscopic and open groups for individual stages. Although Stage I (HR: 1.04, 95 CI 0.68-
1.56) and Stage III (fixed effects HR: 0.99, 95 CI 0.81-1.20; random effects HR: 0.97, 95 CI: 
0.70-1.35) were completely equivalent, there was a non-significant survival trend with the 





Whilst the uptake of laparoscopic colectomy has been slower over the last three decades than 
other minimally invasive techniques, its use has become prevalent, and up to 25% of surgery 
for elective colorectal cancer in Australia is now performed laparoscopically
24
. Laparoscopic 
colectomy has even been proposed as the new gold standard for colectomy by some 
advocates
20
. As with many new techniques, the initial focus has been on short term outcomes, 
but with the results of several large randomised controlled trials being published attention has 
been redirected to the long term oncological results.  
 
This is the first meta-analysis to look at long term survival outcomes using time to event 
outcomes, the log hazard ratio, across all the major randomised controlled trials that have 
assessed laparoscopic versus open surgery for colon cancer and therefore has the largest 
number of patients (n=3152) compared to previous meta-analyses
8, 11, 13, 15
. Moreover, this 
large data collection allows analysis by stage to be more meaningful by increasing the power. 
Stage specific analysis was performed using data from all included studies at five years and 
showed equivalence in overall survival for each stage. Prior to this study, only the meta-
analysis by Bonjer et al
4
, which reported similar overall survival by Stage at three years 
across four RCTs (n=1536 patients) had looked at stage specific data. 
 
This study is unique because most systemic reviews and meta-analyses in the past have 







. None have looked at colon-only data across all major trials. 
Overall numbers in previous studies are small. A recent meta-analysis with large numbers by 
Ma
15
, showed similar results (OR =0.87, CI 0.73-1.73) when looking at ten studies with 
9 
 
results on overall survival without excluding rectal cancers. In addition time to events had not 
been accounted for in the combined results of that study.  
 
The results for all patients, in our study, are in keeping with those from previous meta-
analyses
2, 8, 11, 15
 and the study results themselves, as expected. There was also no significant 
difference in overall survival when looking at individual stages.  The Barcelona trial
12
, which 
had the lightest weighting in this meta-analysis, showed a survival benefit for laparoscopic 
surgery in the Stage III subgroup. The COST trial
7
 however showed a survival benefit for 
those Stage I patients undergoing open colectomy. Neither of these results are supported 
when looking at aggregate stage data as in this study. 
 
Interestingly, when looking at Stage II in this meta-analysis, there was a non-significant trend 
for survival benefit in favour of open surgery (fig. 1). Outcomes for Stage II colon cancer 
may be a better marker for the contribution of surgical technique to survival. Few of these 
patients receive chemotherapy
17
 and so differences in survival outcomes can be attributable 
to surgical technique and quality. Furthermore, there is evidence that compared to Stage I 
colon cancers, there is a significant recurrence rate amongst Stage II
17
 cohorts and so analysis 





This meta-analysis is limited by the studies included which are all large scale RCTs with 
strict inclusion criteria.  For instance, transverse colon cancers were excluded in all, and these 
results therefore cannot necessarily be extrapolated to such patients. In addition, it is possible 
that this meta-analysis is still underpowered to show significant differences and more work is 
required to validate laparoscopic surgery, especially in patients with Stage II disease. Trials 
10 
 
are unlikely to be able to provide the power for this type of analysis that would probably be 
better served by studying larger population based datasets, which also overcomes the 


























A meta-analysis of five clinical trials involving a large series of patients with colon cancer in 
whom there is now long term follow-up confirms equivalence of long term survival outcomes 
for laparoscopic assisted versus open colon surgery. It is indicative of the oncological safety 
of laparoscopic colectomy. This result is independent of stage. Whether these outcomes can 
be reproduced in the community setting where there are no strict inclusion criteria as with 
trials, is yet to be determined. More work on population studies looking at morbidity and 
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Figure 1: Highly sensitive search strategy (HSSS) terms 
 
Figure 2: CONSORT diagram demonstrating study selection process 
 
Figure 3: Forest plots for Stages I-III and overall 
 I-V pooled effects = Inverse-variance weighted fixed effects model. D+L pooled effects = 
DerSimonian and Laird random effects method 
 
Table 1: Characteristics of included studies and risk of bias assessment 
 









Figure 3. Forest plots for Stages I–III and overall I-V pooled effects = Inverse-variance weighted fixed 





Table 1. Characteristics of included studies and risk of bias assessment. 
 
Trial name COST COLOR CLASICC Barcelona ALCCAS 
Region US Europe UK Spain Australia 






July 1998 to 
July 2002 
November 
1993 to July 
1998 
January 1998 
to April 2005 
Single/multicentre 











Number of patients 
  Laparoscopy 435 534 273a 106 294 
  Open 428 542 140a 102 298 
Mean (median) age (years) 
  Laparoscopy 70 71 (69) (68) (71) 
  Open 69 71 (69) (71) (69) 
Number of male patients (%) 
  Laparoscopy 51 52 56 50 47 
  Open 49 53 54 45 48 
Stages I–III I–III A–C2 I–III I–III 
Median follow-up 
(months) 
84 54 70 95 62 
Risk of bias assessment 
  Selection bias 
   Random allocation Unclear Yes Yes Yes Yes 
   Concealment Unclear Unclear Unclear Yes Unclear 
Performance bias 
  Blinding No No No No No 
Detection bias 
  Outcome reporting Yes Yes Yes Yes Yes 
  Blinding No No No No No 
  Completeness Yes Yes Yes Yes Yes 
     a Colon only figures for CLASICC obtained directly from the study statistician. 
 
